These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29451047)

  • 21. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
    Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current advances in the understanding and treatment of mevalonate kinase deficiency.
    Esposito S; Ascolese B; Senatore L; Bosis S; Verrecchia E; Cantarini L; Rigante D
    Int J Immunopathol Pharmacol; 2014; 27(4):491-8. PubMed ID: 25572728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of mevalonate-5-phosphate using UPLC-MS/MS for determination of mevalonate kinase activity.
    Reitzle L; Maier B; Stojanov S; Teupser D; Muntau AC; Vogeser M; Gersting SW
    Clin Biochem; 2015 Aug; 48(12):781-7. PubMed ID: 25982894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and clinical features of hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) and spectrum of mevalonate kinase (MVK) mutations in German children.
    Lainka E; Neudorf U; Lohse P; Timmann C; Bielak M; Stojanov S; Huss K; von Kries R; Niehues T
    Rheumatol Int; 2012 Oct; 32(10):3253-60. PubMed ID: 22038276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homozygous V377I mutation causing mevalonate kinase.
    Brito T; Banganho D; Pedrosa C; Farela Neves J
    BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35387795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mevalonate kinase deficiency in 2016].
    Galeotti C; Georgin-Lavialle S; Sarrabay G; Touitou I; Koné-Paut I
    Rev Med Interne; 2018 Apr; 39(4):265-270. PubMed ID: 27659743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe early-onset colitis revealing mevalonate kinase deficiency.
    Levy M; Arion A; Berrebi D; Cuisset L; Jeanne-Pasquier C; Bader-Meunier B; Jung C
    Pediatrics; 2013 Sep; 132(3):e779-83. PubMed ID: 23979089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and cellular consequences of mevalonate kinase deficiency.
    Politiek FA; Turkenburg M; Henneman L; Ofman R; Waterham HR
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167177. PubMed ID: 38636615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated immunoglobulin D levels in children with PFAPA syndrome.
    Kovacs L; Hlavatá A; Baldovič M; Paulovicova E; Dallos T; Fehérvízyová Z; Kadasi L
    Neuro Endocrinol Lett; 2010; 31(6):743-6. PubMed ID: 21196927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency.
    Tricarico PM; Romeo A; Gratton R; Crovella S; Celsi F
    Cell Physiol Biochem; 2017; 41(4):1649-1660. PubMed ID: 28359055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the mevalonate kinase (MVK) gene cause nonsyndromic retinitis pigmentosa.
    Siemiatkowska AM; van den Born LI; van Hagen PM; Stoffels M; Neveling K; Henkes A; Kipping-Geertsema M; Hoefsloot LH; Hoyng CB; Simon A; den Hollander AI; Cremers FPM; Collin RWJ
    Ophthalmology; 2013 Dec; 120(12):2697-2705. PubMed ID: 24084495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.
    Mandey SH; Schneiders MS; Koster J; Waterham HR
    Hum Mutat; 2006 Aug; 27(8):796-802. PubMed ID: 16835861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When neonatal inflammation does not mean infection: an early-onset mevalonate kinase deficiency with interstitial lung disease.
    Pietrasanta C; Minoia F; Torreggiani S; Ronchi A; Gattorno M; Volpi S; Ceccherini I; Mosca F; Filocamo G; Pugni L
    Clin Immunol; 2019 Aug; 205():25-28. PubMed ID: 31096039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.
    Politiek FA; Waterham HR
    Front Immunol; 2021; 12():724991. PubMed ID: 34539662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Putative modifier genes in mevalonate kinase deficiency.
    Marcuzzi A; Vozzi D; Girardelli M; Tricarico PM; Knowles A; Crovella S; Vuch J; Tommasini A; Piscianz E; Bianco AM
    Mol Med Rep; 2016 Apr; 13(4):3181-9. PubMed ID: 26935981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incomplete mitophagy in the mevalonate kinase-deficient Saccharomyces cerevisiae and its relation to the MKD-related autoinflammatory disease in humans.
    Santos MMS; Gatica D; de Azêvedo Silva J; Crovella S; Klionsky DJ; De Morais MA
    Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166053. PubMed ID: 33385519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periodic fever in MVK deficiency: a patient initially diagnosed with incomplete Kawasaki disease.
    Thors VS; Vastert SJ; Wulffraat N; van Royen A; Frenkel J; de Sain-van der Velden M; de Koning TJ
    Pediatrics; 2014 Feb; 133(2):e461-5. PubMed ID: 24470648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency.
    Galeotti C; Meinzer U; Quartier P; Rossi-Semerano L; Bader-Meunier B; Pillet P; Koné-Paut I
    Rheumatology (Oxford); 2012 Oct; 51(10):1855-9. PubMed ID: 22740624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory deficiency in yeast mevalonate kinase deficient may explain MKD-associate metabolic disorder in humans.
    Santos MMS; Elsztein C; De Souza RB; Paiva SSL; Silva JA; Crovella S; De Morais MA
    Curr Genet; 2018 Aug; 64(4):871-881. PubMed ID: 29374778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased core body temperature exacerbates defective protein prenylation in mouse models of mevalonate kinase deficiency.
    Munoz MA; Skinner OP; Masle-Farquhar E; Jurczyluk J; Xiao Y; Fletcher EK; Kristianto E; Hodson MP; O'Donoghue SI; Kaur S; Brink R; Zahra DG; Deenick EK; Perry KA; Robertson AA; Mehr S; Hissaria P; Mulders-Manders CM; Simon A; Rogers MJ
    J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 36189795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.